• Home
  • NSMCE2, a novel super-enhancer-regulated gene, is linked to poor prognosis and therapy resistance in breast cancer.

NSMCE2, a novel super-enhancer-regulated gene, is linked to poor prognosis and therapy resistance in breast cancer.

Author List
Di Benedetto C, Oh J, Choudhery Z, Shi W, Valdes G, Betancur P
Publication
BMC cancer
Publication ID (Profile URL)
https://researcherprofiles.org/profile/366105613
Publication Year
2022
PubMed ID
36224576
Publication Title
Di Benedetto C, Oh J, Choudhery Z, Shi W, Valdes G, Betancur P. NSMCE2, a novel super-enhancer-regulated gene, is linked to poor prognosis and therapy resistance in breast cancer. BMC Cancer. 2022 Oct 12; 22(1):1056.